Sun Pharma is weighted down by its own corporate governance issues
Sun Pharma has streamlined its operations over the past few years and appears to have addressed the immediate issues that plague...
SEBI’s denial of L&T’s buyback rekindles an old debate
SEBI’s rejection of Larsen & Toubro Limited’s (L&T) buyback raises questions on whether financial metrics should be considered at a...
Let sleeping dogs sleep
Every once in a way an idea takes hold which is supposed to be the panacea for a specific problem plaguing the local equity markets....
Sun Pharma: What investors should ask of its board
The whistle-blower allegations have raised governance concerns at Sun Pharma. Given its current structure, and the new SEBI-accepted...
Fifty shades of green: focussing on ESG and its reporting
At the Asian Corporate Governance Association annual meet in mid-November, in an audience poll, there was near unanimity that boards have...
What next for IL&FS
The government has superseded the board of Infrastructure Leasing and Finance Company Limited (IL&FS). What should the board now do, to...
Boards should be tasked with saving promoters from themselves
This article is the fourth of a series on ‘Board Failures’ that appeared in Bloomberg Quint. Being an independent director on a board is...
#NotJustMeToo: Including stakeholders in the corporate governance agenda
Companies need to include stakeholders in their corporate governance agenda. While companies fight hard to balance their operating...
Could Chanda Kochhar have kept her job at ICICI Bank?
Chanda Kochhar has resigned from ICICI Bank, yet the events that led to her resignation, continue to cast a shadow over its Board. In a...
Board seats – a right or a privilege?
Recent instances of board members holding onto their seats against several odds has created a broader debate on whether being on a board...